statistiche ricercatore

Continente	#
NA - Nord America	1.319
AS - Asia	433
EU - Europa	382
SA - Sud America	67
Continente sconosciuto - Info sul continente non disponibili	19
AF - Africa	11
OC - Oceania	1
Totale	2.232

Nazione	#
US - Stati Uniti d'America	1.267
SG - Singapore	149
GB - Regno Unito	98
CN - Cina	92
IT - Italia	84
VN - Vietnam	63
BR - Brasile	51
SE - Svezia	47
HK - Hong Kong	46
DE - Germania	45
BD - Bangladesh	27
CA - Canada	22
FI - Finlandia	21
FR - Francia	20
RU - Federazione Russa	19
IN - India	15
MX - Messico	14
AR - Argentina	8
BG - Bulgaria	8
IQ - Iraq	8
LT - Lituania	8
BE - Belgio	7
KR - Corea	7
UA - Ucraina	6
DZ - Algeria	5
ID - Indonesia	5
PK - Pakistan	5
AT - Austria	4
JM - Giamaica	4
PL - Polonia	4
GT - Guatemala	3
VE - Venezuela	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
JP - Giappone	2
MY - Malesia	2
NL - Olanda	2
PE - Perù	2
TT - Trinidad e Tobago	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
AG - Antigua e Barbuda	1
AL - Albania	1
AZ - Azerbaigian	1
BB - Barbados	1
BO - Bolivia	1
BS - Bahamas	1
BY - Bielorussia	1
CH - Svizzera	1
CO - Colombia	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
EG - Egitto	1
ES - Italia	1
EU - Europa	1
GP - Guadalupe	1
IE - Irlanda	1
JO - Giordania	1
KG - Kirghizistan	1
KZ - Kazakistan	1
MA - Marocco	1
MD - Moldavia	1
NZ - Nuova Zelanda	1
OM - Oman	1
PA - Panama	1
PT - Portogallo	1
RO - Romania	1
SA - Arabia Saudita	1
SC - Seychelles	1
SI - Slovenia	1
TH - Thailandia	1
TR - Turchia	1
Totale	2.215

Nome	#
Physician–patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy	297
Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates – Italian Registry Hidradenitis Suppurativa project 2	261
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients	251
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis	246
Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light	243
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study	242
Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience	228
From north to south: exploring Italian sun-exposure habits through the “Save your skin” campaign	207
Advances in ultrafast plasmonics	191
Clinical management of pigmented purpuric dermatoses: evidence from a survey among the Study Group on Cutaneous Vascular Diseases of the Italian Society of Dermatology and Venereology	66
Totale	2.232

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	154	0	0	0	12	3	23	1	8	16	10	64	17
2022/2023	151	20	23	10	19	24	17	2	8	11	3	5	9
2023/2024	92	2	1	11	17	17	4	17	5	2	1	11	4
2024/2025	351	10	3	4	42	67	48	23	23	40	23	30	38
2025/2026	728	52	21	33	52	96	36	74	33	68	79	76	108
2026/2027	308	88	77	71	72	0	0	0	0	0	0	0	0
Totale													2.232